BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25246998)

  • 21. Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques.
    Devasundaram S; Rosati M; Valentin A; Weiss S; Itri V; Trinh HV; Bear J; Chowdhury B; LaBranche CC; Montefiori D; Ferrari G; Rao M; Kong XP; Zolla-Pazner S; Pavlakis GN; Felber BK
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.
    Pollara J; Bonsignori M; Moody MA; Liu P; Alam SM; Hwang KK; Gurley TC; Kozink DM; Armand LC; Marshall DJ; Whitesides JF; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Robb ML; O'Connell RJ; Kim JH; Michael NL; Montefiori DC; Tomaras GD; Liao HX; Haynes BF; Ferrari G
    J Virol; 2014 Jul; 88(14):7715-26. PubMed ID: 24807721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RV144 HIV-1 vaccination impacts post-infection antibody responses.
    Mdluli T; Jian N; Slike B; Paquin-Proulx D; Donofrio G; Alrubayyi A; Gift S; Grande R; Bryson M; Lee A; Dussupt V; Mendez-Riveria L; Sanders-Buell E; Chenine AL; Tran U; Li Y; Brown E; Edlefsen PT; O'Connell R; Gilbert P; Nitayaphan S; Pitisuttihum P; Rerks-Ngarm S; Robb ML; Gramzinski R; Alter G; Tovanabutra S; Georgiev IS; Ackerman ME; Polonis VR; Vasan S; Michael NL; Kim JH; Eller MA; Krebs SJ; Rolland M
    PLoS Pathog; 2020 Dec; 16(12):e1009101. PubMed ID: 33290394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
    Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
    J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Forms of TFF3 in the Human Saliva: Heterodimerization with IgG Fc Binding Protein (FCGBP).
    Houben T; Harder S; Schlüter H; Kalbacher H; Hoffmann W
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
    Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
    PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
    Rerks-Ngarm S; Pitisuttithum P; Excler JL; Nitayaphan S; Kaewkungwal J; Premsri N; Kunasol P; Karasavvas N; Schuetz A; Ngauy V; Sinangil F; Dawson P; deCamp AC; Phogat S; Garunathan S; Tartaglia J; DiazGranados C; Ratto-Kim S; Pegu P; Eller M; Karnasuta C; Montefiori DC; Sawant S; Vandergrift N; Wills S; Tomaras GD; Robb ML; Michael NL; Kim JH; Vasan S; O'Connell RJ;
    J Infect Dis; 2017 Apr; 215(8):1255-1263. PubMed ID: 28329190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.
    Wines BD; Billings H; Mclean MR; Kent SJ; Hogarth PM
    Curr HIV Res; 2017; 15(3):202-215. PubMed ID: 28322167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.
    Veillette M; Coutu M; Richard J; Batraville LA; Dagher O; Bernard N; Tremblay C; Kaufmann DE; Roger M; Finzi A
    J Virol; 2015 Jan; 89(1):545-51. PubMed ID: 25339767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission.
    Cheeseman HM; Carias AM; Evans AB; Olejniczak NJ; Ziprin P; King DF; Hope TJ; Shattock RJ
    PLoS One; 2016; 11(5):e0154656. PubMed ID: 27164006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune correlates of vaccine protection against HIV-1 acquisition.
    Corey L; Gilbert PB; Tomaras GD; Haynes BF; Pantaleo G; Fauci AS
    Sci Transl Med; 2015 Oct; 7(310):310rv7. PubMed ID: 26491081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.
    Edlefsen PT; Rolland M; Hertz T; Tovanabutra S; Gartland AJ; deCamp AC; Magaret CA; Ahmed H; Gottardo R; Juraska M; McCoy C; Larsen BB; Sanders-Buell E; Carrico C; Menis S; Kijak GH; Bose M; ; Arroyo MA; O'Connell RJ; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Rerks-Ngarm S; Robb ML; Kirys T; Georgiev IS; Kwong PD; Scheffler K; Pond SL; Carlson JM; Michael NL; Schief WR; Mullins JI; Kim JH; Gilbert PB
    PLoS Comput Biol; 2015 Feb; 11(2):e1003973. PubMed ID: 25646817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection.
    Zolla-Pazner S; deCamp A; Gilbert PB; Williams C; Yates NL; Williams WT; Howington R; Fong Y; Morris DE; Soderberg KA; Irene C; Reichman C; Pinter A; Parks R; Pitisuttithum P; Kaewkungwal J; Rerks-Ngarm S; Nitayaphan S; Andrews C; O'Connell RJ; Yang ZY; Nabel GJ; Kim JH; Michael NL; Montefiori DC; Liao HX; Haynes BF; Tomaras GD
    PLoS One; 2014; 9(2):e87572. PubMed ID: 24504509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
    Kibler KV; Asbach B; Perdiguero B; García-Arriaza J; Yates NL; Parks R; Stanfield-Oakley S; Ferrari G; Montefiori DC; Tomaras GD; Roederer M; Foulds KE; Forthal DN; Seaman MS; Self S; Gottardo R; Phogat S; Tartaglia J; Barnett S; Cristillo AD; Weiss D; Galmin L; Ding S; Heeney JL; Esteban M; Wagner R; Pantaleo G; Jacobs BL
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens.
    Karnasuta C; Akapirat S; Madnote S; Savadsuk H; Puangkaew J; Rittiroongrad S; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Tartaglia J; Sinangil F; Francis DP; Robb ML; de Souza MS; Michael NL; Excler JL; Kim JH; O'Connell RJ; Karasavvas N
    AIDS Res Hum Retroviruses; 2017 May; 33(5):410-423. PubMed ID: 28006952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Correlates of Disease Progression in Linked HIV-1 Infection.
    Tuen M; Bimela JS; Banin AN; Ding S; Harkins GW; Weiss S; Itri V; Durham AR; Porcella SF; Soni S; Mayr L; Meli J; Torimiro JN; Tongo M; Wang X; Kong XP; Nádas A; Kaufmann DE; Brumme ZL; Nanfack AJ; Quinn TC; Zolla-Pazner S; Redd AD; Finzi A; Gorny MK; Nyambi PN; Duerr R
    Front Immunol; 2019; 10():1062. PubMed ID: 31139189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.